FDA Issues Warning on Controversial MS Treatment (Health.com)
05/10/2012
Source: Health.com
By Robert Preidt
Dr. Karen Blitz-Shabbir, director of the Multiple Sclerosis Center at Cushing Neuroscience Institute, discusses the need for caution regarding a new, potentially dangerous treatment for MS.
Read the full story.